Literature DB >> 17487381

Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.

Amos R Mwakigonja1, Fatemeh Pak, Pawan Pyakurel, Innocent J Mosha, Willy K Urassa, Ephata E Kaaya, Peter Biberfeld.   

Abstract

Oral Kaposi's sarcoma (OKS) from Tanzanian patients (78) at Muhimbili National Hospital/Muhimbili University College of Health Sciences corresponding to approximately 10% of KS registered during 1990-2005, were diagnosed (ELISA) as HIV-infected (OAKS) (74/78) and endemic KS (4/78). Females were 69.2% (54/78) with median age 31 and males 30.8% (24/78) with median age 38. More males (50%) had systemic KS than females (37%) and 4-times more multicentric OKS. All tested (34) oral KS patients sera had HHV-8 antibodies. Available (31/78) blood showed very low CD4+ T-lymphocyte counts. Most OKS (61.5%) had nodular histology. Immunostaining showed adult male nodular OAKS to have a significantly higher frequency of viral LANA+, endothelial CD34+ tumour spindle-cells (SC) and more Ki-67+ (median =24.1%) proliferating cells compared to females (17.2%). Juvenile nodular OAKS had more LANA+ and Ki-67+ cells than corresponding adult cases. Significantly more LANA+ and Ki-67+ cells were found in nodular OAKS compared to cutaneous HIV/AIDS Kaposi's sarcoma (CAKS). A positive correlation (60%) was found between the proliferation index (Ki-67+ cell frequency) and LANA+/CD34+ SC. OKS in Tanzania is since 1990, mostly seen in females, associated with HIV/AIDS and advanced (nodular) histopathology. Males have more systemic tumour burden while more females develop primary OAKS. HHV-8+ cells were more frequent in nodular male than female and in juvenile than adult nodular OAKS than cAKS. Higher tumoral HHV-8 content appeared to be correlated to proliferation index.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487381

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

2.  Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association.

Authors:  Amos R Mwakigonja; Ephata E Kaaya; Thomas Heiden; German Wannhoff; Juan Castro; Fatemeh Pak; Anna Porwit; Peter Biberfeld
Journal:  BMC Cancer       Date:  2010-07-01       Impact factor: 4.430

3.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

4.  Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania.

Authors:  Amos Rodger Mwakigonja; Nyanda Elias Lushina; Ally Mwanga
Journal:  Infect Agent Cancer       Date:  2017-11-06       Impact factor: 2.965

Review 5.  HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.

Authors:  Elizabeth M Etta; Doyinmola P Alayande; Lufuno G Mavhandu-Ramarumo; George Gachara; Pascal O Bessong
Journal:  Viruses       Date:  2018-08-27       Impact factor: 5.048

Review 6.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

7.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17

8.  Malignant lymphomas (ML) and HIV infection in Tanzania.

Authors:  Amos R Mwakigonja; Ephata E Kaaya; Edward M Mgaya
Journal:  J Exp Clin Cancer Res       Date:  2008-06-10

9.  The pattern of prognostic and risk indicators among women with breast cancer undergoing modified radical mastectomy in Dar es Salaam, Tanzania.

Authors:  Amos R Mwakigonja; Happiness Rabiel; Naboth A Mbembati; Leonard E K Lema
Journal:  Infect Agent Cancer       Date:  2016-06-30       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.